Beneficial association of serum ghrelin and peptide YY with bone mineral density in the Newfoundland population

BMC Endocrine Disorders

Volumn 13, Issue , 2013, Pages

  Amini, Peyvand ^a   Cahill, Farrell ^a   Wadden, Danny ^a   Ji, Yunqi ^a   Pedram, Pardis ^a   Vidyasankar, Sangeetha ^a   Yi, Yanqing ^a   Gulliver, Wayne ^a   Paterno, Gary ^a   Zhang, Hongwei ^a   Rideout, Alecia ^a   Sun, Guang ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

Bone density; Ghrelin; Osteoporosis; Peptide YY

Indexed keywords

GHRELIN; PEPTIDE YY;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY FAT; BODY MASS; BONE DENSITY; BONE METABOLISM; CANADA; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME LINKED IMMUNOSORBENT ASSAY; FAT MASS; FEMALE; FEMUR NECK; HIP; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; LEAN BODY WEIGHT; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREMENOPAUSE; SMOKING;

EID: 84884384342     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-13-35     Document Type: Article

References (37)

1. International Osteoporosis Foundation: Osteoporosis in the Workplace: The social, economic and human costs of osteoporosis on employees, employers and governments [http://www.iofbonehealth.org/osteoporosis-workplace-report-2002], International Osteoporosis Foundation:.
2. Khosla S, Melton LJ, Riggs BL. The unitary model for estrogen deficiency and the pathogenesis of osteoporosis: is a revision needed?. J Bone Miner Res 2011, 26(3):441-451. 10.1002/jbmr.262, 3179298, 20928874.
3. Bonnick SL. Bone densitometry in clinical practice: application and interpretation 2009, Totowa, NJ, USA: Humana Press.
4. Fukushima N, Hanada R, Teranishi H, Fukue Y, Tachibana T, Ishikawa H, Takeda S, Takeuchi Y, Fukumoto S, Kangawa K, et al. Ghrelin directly regulates bone formation. J Bone Miner Res 2005, 20(5):790-798.
5. Baldock PA, Sainsbury A, Couzens M, Enriquez RF, Thomas GP, Gardiner EM, Herzog H. Hypothalamic Y2 receptors regulate bone formation. J Clin Investig 2002, 109(7):915-922. 150931, 11927618.
6. Kojima M, Kangawa K. Ghrelin: structure and function. Physiol Rev 2005, 85(2):495-522. 10.1152/physrev.00012.2004, 15788704.
7. Hazelwood RL. The pancreatic polypeptide (PP-fold) family: gastrointestinal, vascular, and feeding behavioral implications. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine 1993, 44-63. New York, NY: Royal Society of Medicine.
8. Batterham RL, Cohen MA, Ellis SM, Le Roux CW, Withers DJ, Frost GS, Ghatei MA, Bloom SR. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 2003, 349(10):941-948. 10.1056/NEJMoa030204, 12954742.
9. Kim SW, Her SJ, Park SJ, Kim D, Park KS, Lee HK, Han BH, Kim MS, Shin CS, Kim SY. Ghrelin stimulates proliferation and differentiation and inhibits apoptosis in osteoblastic MC3T3-E1 cells. Bone 2005, 37(3):359-369. 10.1016/j.bone.2005.04.020, 15978880.
10. Maccarinelli G, Sibilia V, Torsello A, Raimondo F, Pitto M, Giustina A, Netti C, Cocchi D. Ghrelin regulates proliferation and differentiation of osteoblastic cells. J Endocrinol 2005, 184(1):249-256. 10.1677/joe.1.05837, 15642801.
11. Gonnelli S, Caffarelli C, Del Santo K, Cadirni A, Guerriero C, Lucani B, Franci B, Nuti R. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int 2008, 83(1):55-60. 10.1007/s00223-008-9149-y, 18563283.
12. Coates PS, Fernstrom JD, Fernstrom MH, Schauer PR, Greenspan SL. Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass. J Clin Endocrinol Metab 2004, 89(3):1061-1065. 10.1210/jc.2003-031756, 15001587.
13. Oh KW, Lee WY, Rhee EJ, Baek KH, Yoon KH, Kang MI, Yun EJ, Park CY, Ihm SH, Choi MG, et al. The relationship between serum resistin, leptin, adiponectin, ghrelin levels and bone mineral density in middle-aged men. Clin Endocrinol (Oxf) 2005, 63(2):131-138.
14. Makovey J, Naganathan V, Seibel M, Sambrook P. Gender differences in plasma ghrelin and its relations to body composition and bone - an opposite-sex twin study. Clin Endocrinol (Oxf) 2007, 66(4):530-537.
15. Weiss LA, Langenberg C, Barrett-Connor E. Ghrelin and bone: is there an association in older adults?: the Rancho Bernardo study. J Bone Miner Res 2006, 21(5):752-757. 10.1359/jbmr.060209, 16734390.
16. Wortley KE, Garcia K, Okamoto H, Thabet K, Anderson KD, Shen V, Herman JP, Valenzuela D, Yancopoulos GD, Tschöp MH. Peptide YY regulates bone turnover in rodents. Gastroenterology 2007, 133(5):1534-1543. 10.1053/j.gastro.2007.08.024, 17920065.
17. Misra M, Miller KK, Tsai P, Gallagher K, Lin A, Lee N, Herzog DB, Klibanski A. Elevated peptide YY levels in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab 2006, 91(3):1027-1033.
18. Stock S, Leichner P, Wong ACK, Ghatei MA, Kieffer TJ, Bloom SR, Chanoine J-P. Ghrelin, Peptide YY, Glucose-Dependent Insulinotropic Polypeptide, and Hunger Responses to a Mixed Meal in Anorexic, Obese, and Control Female Adolescents. J Clin Endocrinol Metab 2005, 90(4):2161-2168. 10.1210/jc.2004-1251, 15657373.
19. Misra M. Bone density in the adolescent athlete. Rev Endocr Metab Disord 2008, 9(2):139-144. 10.1007/s11154-008-9077-1, 18409004.
20. Russell M, Stark J, Nayak S, Miller KK, Herzog DB, Klibanski A, Misra M. Peptide YY in adolescent athletes with amenorrhea, eumenorrheic athletes and non-athletic controls. Bone 2009, 45(1):104-109. 10.1016/j.bone.2009.03.668, 2692763, 19344792.
21. Kanis J. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. Osteoporos Int 1994, 4(6):368-381. 10.1007/BF01622200, 7696835.
22. Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982, 36(5):936-942.
23. Cahill F, Shea JL, Randell E, Vasdev S, Sun G. Serum peptide YY in response to short-term overfeeding in young men. Am J Clin Nutr 2011, 93(4):741-747. 10.3945/ajcn.110.003624, 21289220.
24. dela Cour DC, Lindqvist A, Egecioglu E, Tung YC, Surve V, Ohlsson C, Jansson JO, Erlanson-Albertsson C, Dickson SL, Hakanson R. Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice. Gut 2005, 54(7):907-913. 10.1136/gut.2004.058578, 1774616, 15849166.
25. Delhanty PJD, van der Eerden BCJ, van der Velde M, Gauna C, Pols HAP, Jahr H, Chiba H, van der Lely AJ, van Leeuwen JPTM. Ghrelin and unacylated ghrelin stimulate human osteoblast growth via mitogen-activated protein kinase (MAPK)/phosphoinositide 3-kinase (PI3K) pathways in the absence of GHS-R1a. J Endocrinol 2006, 188(1):37-47. 10.1677/joe.1.06404, 16394173.
26. van der Velde M, van der Eerden BC, Sun Y, Almering JM, van der Lely A-J, Delhanty PJ, Smith RG, van Leeuwen JP. An age-dependent interaction with leptin unmasks ghrelin's bone-protective effects. Endocrinology 2012, 153(8):3593-3602. 10.1210/en.2012-1277, 22700774.
27. Sun Y, Ahmed S, Smith RG. Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 2003, 23(22):7973-7981. 10.1128/MCB.23.22.7973-7981.2003, 262394, 14585959.
28. Adams K, O'Shea P, O'Shea KL. Aging: its effects on strength, power, flexibility, and bone density. Strength Conditioning J 1999, 21(2):65.
29. Whalen RT, Carter DR, Steele CR. Influence of physical activity on the regulation of bone density. J Biomech 1988, 21(10):825-837. 10.1016/0021-9290(88)90015-2, 3225269.
30. Wishart JM, Need AO, Horowitz M, Morris† HA, Nordin BEC. Effect of age on bone density and bone turnover in men. Clin Endocrinol (Oxf) 1995, 42(2):141-146.
31. Baron C. Using the gradient of human cortical bone properties to determine age-related bone changes via ultrasonic guided waves. Ultrasound Med Biol 2012, 38(6):972-981. 10.1016/j.ultrasmedbio.2012.02.024, 22502890.
32. Camhi SM, Katzmarzyk PT. Total and femoral neck bone mineral density and physical activity in a sample of men and women. Appl Physiol Nutr Metab 2012, 37(5):947-954. 10.1139/h2012-075, 22823076.
33. Sampson HW. Alcohol's harmful effects on bone. Alcohol Health Res World 1998, 22:190-194.
34. Nouh O, Abd Elfattah MM, Hassouna AA. Association between ghrelin levels and BMD: a cross sectional trial. Gynecol Endocrinol 2012, 28(7):570-572. 10.3109/09513590.2011.593663, 22657566.
35. Purnell JQ, Weigle DS, Breen P, Cummings DE. Ghrelin Levels Correlate with Insulin Levels, Insulin Resistance, and High-Density Lipoprotein Cholesterol, But Not with Gender, Menopausal Status, or Cortisol Levels in Humans. J Clin Endocrinol Metab 2003, 88(12):5747-5752. 10.1210/jc.2003-030513, 14671163.
36. Utz AL, Lawson EA, Misra M, Mickley D, Gleysteen S, Herzog DB, Klibanski A, Miller KK. Peptide YY (PYY) levels and bone mineral density (BMD) in women with anorexia nervosa. Bone 2008, 43(1):135-139. 10.1016/j.bone.2008.03.007, 2493518, 18486583.
37. Bachrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990, 86(3):440-447.